News

Orion S.A. Announces Noteworthy Interim Dividend for Shareholders

Orion S.A. Announces Noteworthy Interim Dividend for Shareholders

Orion S.A. Announces Interim Quarterly Dividend

Orion S.A. (NYSE: OEC), a notable player in the specialty chemical industry, has shared a significant update for its shareholders. The company’s Board of Directors has announced the declaration of an interim dividend of $0.0207 per common share. This move highlights Orion's dedication to offering returns to its shareholders, all while maintaining a robust financial position.

Dividend Payment Information

This interim dividend is set to be paid in the first quarter of 2025, which is an important milestone for Orion. The total estimated payout is around $1.25 million, based on the current number of common shares outstanding. Shareholders who are on the books as of December 13, 2024, will qualify to receive this dividend. It's crucial to remember that a Luxembourg withholding tax of 15% will apply to each dividend payment, although some exemptions may exist under specific conditions.

What Shareholders Should Consider

For shareholders, this announcement is about more than just numbers; it's also a testament to Orion's ongoing resilience and strategic planning. By declaring this interim dividend, the company showcases its financial strength, ensuring that those who invest in it are rewarded for their support. Generally, investors tend to view companies that prioritize dividends favorably, as it reflects a confidence in their prospects for future earnings.

About Orion S.A.

Orion S.A. is recognized as a leading supplier of carbon black, a vital material used in numerous applications such as tires, coatings, and batteries. The company takes pride in producing carbon black that meets strict customer specifications, contributing significantly to its reputation for quality and performance. With innovation centers spread across three continents, Orion not only offers a diverse range of production methods but also places a strong emphasis on sustainability in its operations.

A Legacy of Innovation

Tracing its origins over 160 years back to Germany, Orion S.A. runs one of the world's longest-standing carbon black plants. This rich legacy is combined with a firm commitment to innovation, enabling Orion to deliver tailored solutions that meet the evolving needs of its customers. The company continually aims to enhance its processes and products, ensuring it remains a leader in the industry.

Commitment to Growth and Sustainability

Orion S.A. focuses not only on financial returns but is also strongly committed to environmental sustainability. Carbon black is essential in various applications due to its unique features, including reinforcement and UV protection. By promoting sustainable practices, Orion is leading the charge for greener solutions in the specialty chemical landscape, addressing both consumer requirements and environmental concerns.

Looking Ahead for Orion S.A.

As Orion S.A. continues to evolve, the prospect of future dividends alongside ongoing growth initiatives points to a positive outlook for the company. Stakeholders can feel reassured knowing that Orion is committed to innovation-driven, sustainable solutions while also upholding a solid financial foundation. This current dividend declaration not only serves as a reward for shareholders but also signals the potential for ongoing growth and progress in the chemical sector.

Frequently Asked Questions

What is the amount of the interim dividend declared by Orion S.A.?

The declared interim dividend is $0.0207 per common share.

When will the interim dividend be paid to shareholders?

The interim dividend is scheduled for payment on January 21, 2025.

Who is eligible to receive the interim dividend?

Holders of record as of the close of business on December 13, 2024, will be eligible for the dividend.

What kind of tax will be deducted from the interim dividend?

A Luxembourg withholding tax of 15% will be deducted from each interim dividend payment.

What does Orion S.A. specialize in?

Orion S.A. specializes in producing carbon black for various high-performance applications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

Updated Category News Views 54

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 70

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 0

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Coastal Financial Faces Class Action Suit Over Securities

Updated Category News Views 78

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 101

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance

Updated Category News Views 53

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Continue Reading
Dizal Unveils Promising Data at ASH 2026

Updated Category News Views 72

Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...

Continue Reading
LOA Roofing's Growth Recap Taps Southstone's Backing

Updated Category News Views 107

Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 17

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation

Updated Category News Views 48

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...

Continue Reading

Top 5 Most Recently Viewed Articles

SKYX Technologies Expands Market Presence with Insider Investments

Updated Category News Views 166

SKYX Technologies' Corporate Developments SKYX Technologies, also known as SKYX (NASDAQ: SKYX), is taking significant strides in the smart technology sector. This dynamic company focuses on transforming homes and buildings into smarter, safer, and more advanced spaces. With a remarkable portfolio of over 97 issued and pending patents, SKYX aims to set a new standard in...

Continue Reading
Crinetics Pharmaceuticals Expands Workforce With Stock Options

Updated Category News Views 195

Crinetics Pharmaceuticals Enhances Employee Incentives In a recent announcement, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), based in San Diego, revealed a significant step in enhancing employee incentives and strengthening its workforce. On October 10, 2025, the company’s Compensation Committee authorized the granting of stock options and restricted stock units...

Continue Reading
Manulife Investment Management Earns Top Recognition in Sustainable Finance

Updated Category News Views 199

Manulife Investment Management Recognized for Excellence In a significant acknowledgment of its leadership in sustainable finance, Manulife Investment Management (Manulife IM) has made it to the prestigious list of IPE Real Assets' Top 50 Natural Capital Managers. This recognition comes as the firm is gearing up for robust fundraising activities, with an exciting fund...

Continue Reading
Vaxart Reports Progress and Financial Performance for Q3 2025

Updated Category News Views 213

Vaxart’s Business Progress and Financial Results Overview Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, recently provided a significant update on its business and reported its financial outcomes for the third quarter of 2025. This latest communication showcases exciting developments in their oral recombinant vaccine platform, which is designed to...

Continue Reading
Madrigal Pharmaceuticals Marks Enrollment Milestone in NASH Study

Updated Category News Views 47

Madrigal Pharmaceuticals Achieves Enrollment Milestone in NASH Study Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, has announced a significant milestone in their MAESTRO-NASH OUTCOMES clinical trial. This study evaluates the efficacy of resmetirom in patients diagnosed with...

Continue Reading